Master of Science - Advanced Biomedical Science (B90074)

MSc Advanced Biomedical Science — carrying the course code recorded in the source — develops specialist knowledge across the diagnostic disciplines: advanced clinical biochemistry, haematology, immunology, medical microbiology and molecular pathology, with research methods and a substantial laboratory or research project.

The programme suits biomedical and life science graduates seeking depth, international candidates aligning qualifications with UK practice, and practising scientists progressing toward specialist and leadership grades within pathology services.

Laboratory and research training is emphasised alongside the clinical science, since the destinations — specialist diagnostics, research, trials and quality management — all require demonstrable technical competence rather than theoretical knowledge alone.

Registration questions should be settled before enrolment rather than after, because they determine the value of the year: candidates already registered or registration-eligible use this master’s to advance toward specialist grades, while international graduates seeking UK laboratory practice need to understand that HCPC registration follows an accredited route with a portfolio completed in an approved laboratory, which this course does not itself provide. DMU admissions can clarify the current position for a given background. Employment in research, trials and industry laboratories is available regardless, at the £17,800 fee across three recorded September cycles. Applicants should also present their undergraduate laboratory experience in detail, since technique-level competence is what distinguishes candidates for research and trials employment afterwards. Attendance requirements are heavier than for non-laboratory master’s courses.

Employment spans NHS pathology, pharmaceutical and biotechnology laboratories, contract research and academic research groups. The master’s carries Graduate Route eligibility at 18 months under the post-January-2027 settlement, with dependants excluded on taught postgraduate routes.